Skip to main content
Premium Trial:

Request an Annual Quote

Infinity Bio Antibody Profiling Service

Infinity Bio has launched an antibody profiling service using MIPSA (molecular indexing of proteins by self-assembly) technology. The company said that its current catalog of antigen panels — VirSIGHT, HuSIGHT, and AllerSIGHT — blend full-length protein and peptide libraries to provide in-depth assays for detecting antibodies targeting all human viruses, self-proteins, or allergic proteins, respectively, in a single test. Infinity said that its science-as-a-service model provides detailed, comprehensive, and reproducible antibody-response analyses for cohort studies, clinical trials, vaccine development, immune-oncology therapeutics, biomarker discovery, and monoclonal antibody characterization.